The Growing Market for Weight Loss Treatments: Innovation, Patents, and the Future of GLP-1 AgonistsThe pharmaceutical industry's focus is shifting toward weight loss and diabetes treatments, driven by innovation and patent strategies.
Europe's most valuable company Novo Nordisk reports a slight increase in profitsNovo Nordisk posted a slight increase in net profit for the second quarter and raised its forecast for the full year due to increased demand for its diabetes and obesity treatments.
The Growing Market for Weight Loss Treatments: Innovation, Patents, and the Future of GLP-1 AgonistsThe pharmaceutical industry's focus is shifting toward weight loss and diabetes treatments, driven by innovation and patent strategies.
Europe's most valuable company Novo Nordisk reports a slight increase in profitsNovo Nordisk posted a slight increase in net profit for the second quarter and raised its forecast for the full year due to increased demand for its diabetes and obesity treatments.
Exclusive | Facebook has become the place to sell leftover Ozempic, other weight loss drugs - as NYC sellers take advantage of shortages and high pricesNew Yorkers are illegally reselling prescription medications like Ozempic and Mounjaro online, risking severe legal consequences amid skyrocketing demand and scarcity.